Transporter-Targeted Bile Acid-Camptothecin Conjugate for Improved Oral Absorption

Chem Pharm Bull (Tokyo). 2019 Oct 1;67(10):1082-1087. doi: 10.1248/cpb.c19-00341. Epub 2019 Aug 6.

Abstract

Camptothecin (CPT), a natural alkaloid, possesses potent anticancer activity. However, its application was terminated due to its low bioavailability and high toxicity. This work evaluated the potential of deoxycholic acid-CPT conjugate (G2) to improve the oral absorption of CPT. Deoxycholic acid significantly reduced cytotoxicity and inhibited the uptake of G2, in vitro. And G2 showed sodium-dependent uptake. In addition, in vivo study in rats indicated that the oral bioavailability of G2 was 2.06-fold higher than that of CPT. The present study suggested that using bile acid as the conjugated moiety is a hopeful strategy to improve the oral bioavailability of CPT.

Keywords: bioavailability; camptothecin; conjugate; cytotoxicity; deoxycholic acid; uptake.

MeSH terms

  • Absorption, Physiological
  • Administration, Oral
  • Animals
  • Bile Acids and Salts / administration & dosage*
  • Bile Acids and Salts / chemistry*
  • Bile Acids and Salts / pharmacology
  • Caco-2 Cells
  • Camptothecin / administration & dosage*
  • Camptothecin / chemistry*
  • Camptothecin / pharmacology
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Humans
  • Male
  • Molecular Conformation
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Bile Acids and Salts
  • Camptothecin